Interim Report 2025 中期報告 二零二五年中期報告 – 高陽科技（中國）有限公司 1 Contents 目錄 HI SUN TECHNOLOGY (CHINA) LIMITED – INTERIM REPORT 2025 Business Review 業務回顧 Business Review 業務回顧 INTERIM CONDENSED SEGMENT RESULT ANALYSIS 中期簡明分類業績分析 | | | | Turnover | | EBITDA# | | | --- | --- | --- | --- | --- | --- | --- | | | | | 營業額 | | EBITDA# | | | | | | Unaudited | | Unaudited | | | | | | 未經審核 | | 未經審核 | | | | | | 1H2025 二零二五年 | 1H2024 二零二四年 | 1H2025 二零二五年 | 1H2024 二零二四年 | | | | | 上半年 | 上半年 | 上半年 | 上半年 | | | | Notes | HK$'000 | HK$'00 ...

Interim Report 中期報告 2025 A920MAX 1 百富環球科技有限公司 | 二零二五年中期報告 Content 目錄 2 Corporate Information 公司資料 4 Management Discussion and Analysis 管理層之討論與分析 17 Additional Information 其他資料 26 Interim Condensed Consolidated Income Statement 中期簡明綜合收益表 27 Interim Condensed Consolidated Statement of Comprehensive Income 中期簡明綜合全面收益表 28 Interim Condensed Consolidated Balance Sheet 中期簡明綜合資產負債表 30 Interim Condensed Consolidated Statement of Changes in Equity 中期簡明綜合權益變動表 32 Interim Condensed Consolidated Cash Flow Statement 中期簡明 ...

2025 INTERIM REPORT 中期報告 GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange. Prospective investors should be aware of the potential risks of investing in such companies and should make the decision to invest only after due and careful consideration. Given that the companies listed on GEM are generally small and mid-sized companies, there is a risk that securities traded ...

香港交易及結算所有限公司及香港聯合交易所有限公司（「香港聯交所」）對本公告的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示概不會就本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任 何損失承擔任何責任。 Trip.com Group Limited 攜程集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：9961） 2025 年第二季度及上半年業績公告 攜程集團有限公司謹此公佈其2025年第二季度及上半年業績（「2025年第二季度及上半年 業績公告」）。2025年第二季度及上半年業績公告乃作為我們根據香港聯交所證券上市 規則（「《香港上市規則》」）第13.48(1)條截至2025年6月30日止六個月的中期報告向股東提 供。2025年第二季度及上半年業績公告可於香港聯交所網站 www.hkexnews.hk 及本公司 網站 investors.trip.com 查閱。 承董事會命 攜程集團有限公司 董事會執行主席 梁建章 新加坡，2025年8月28日 於本公告日期，本公司董事會包括董事梁建章先生、范敏先生、孫潔女士及羅戎先生以及獨立董事沈南鵬先生、 季琦先生、李基培先生及甘劍平先生 ...

[Report Overview and Company Information](index=1&type=section&id=%E5%A0%B1%E5%91%8A%E6%A6%82%E8%A7%88%E8%88%87%E5%85%AC%E5%8F%B8%E4%BF%A1%E6%81%AF) [Legal Disclaimer and Announcement Details](index=1&type=section&id=%E6%B3%95%E5%BE%8B%E8%81%B2%E6%98%8E%E8%88%87%E5%85%AC%E5%91%8A%E8%A9%B3%E6%83%85) This announcement presents Noah Holdings Private Wealth Asset Management Limited's unaudited Q2 2025 financial results, issued under HKEX Listing Rules and SFO, advising investor caution - Announcement issued under HKEX Listing Rule 13.09 and SFO Part XIVA inside information provisions[4](index=4&type=chunk) - Q2 2025 results prepared under US GAAP, differing from IFRS[4](index=4&type=chunk) - Interim results for the six months ended June 30, 2025, expected to be published on August 28, 2025 (HKT)[4](index=4&type=chunk) [Company Profile and Reporting Structure Adjustment](index=2&type=section&id=%E5%85%AC%E5%8F%B8%E7%B0%A1%E4%BB%8B%E8%88%87%E5%A0%B1%E5%91%8A%E7%B5%90%E6%A7%8B%E8%AA%BF%E6%95%B4) Noah Holdings Limited announced Q2 2025 unaudited financial results, adopting a refined segment reporting structure from Q4 2024 to disclose net revenue by onshore and offshore business segments - Noah Holdings Limited is a leading wealth management service provider, offering global investment and asset allocation advisory services to high-net-worth Chinese investors worldwide[8](index=8&type=chunk) - From Q4 2024, the company adopted a refined segment reporting structure, disclosing net revenue by onshore and offshore business segments, with Q4 2024 comparative data restated[8](index=8&type=chunk) [Q2 2025 Financial and Operational Highlights](index=2&type=section&id=2025%E5%B9%B4%E7%AC%AC%E4%BA%8C%E5%AD%A3%E5%BA%A6%E8%B2%A1%E5%8B%99%E8%88%87%E7%B6%93%E7%87%9F%E6%91%98%E8%A6%81) [Q2 2025 Financial Highlights](index=2&type=section&id=2025%E5%B9%B4%E7%AC%AC%E4%BA%8C%E5%AD%A3%E5%BA%A6%E8%B2%A1%E5%8B%99%E6%91%98%E8%A6%81) In Q2 2025, Noah Holdings' net revenue increased by 2.2% year-over-year to RMB 629.5 million, operating income grew by 20.2%, and net income attributable to Noah shareholders surged by 79.0% to RMB 178.6 million Q2 2025 Key Financial Metrics Overview | Metric | Q2 2025 (RMB million) | Q2 2024 (RMB million) | YoY Change | | :--- | :--- | :--- | :--- | | Net Revenue | 629.5 | 615.8 | +2.2% | | Operating Income | 161.0 | 134.0 | +20.2% | | Net Income Attributable to Noah Shareholders | 178.6 | 99.8 | +79.0% | | Non-GAAP Net Income Attributable to Noah Shareholders | 189.0 | 106.1 | +78.2% | - Net revenue growth primarily due to increased distribution of offshore private securities investment funds and onshore private securities investment funds[10](index=10&type=chunk) [Q2 2025 Operational Performance](index=2&type=section&id=2025%E5%B9%B4%E7%AC%AC%E4%BA%8C%E5%AD%A3%E5%BA%A6%E7%B6%93%E7%87%9F%E6%83%85%E6%B3%81) Noah achieved growth in client numbers and total value of distributed products in Q2 2025, particularly strong in offshore clients and private securities investment funds, while AUM remained relatively stable with offshore AUM increasing Q2 2025 Client and Product Distribution Data | Metric | As of June 30, 2025 | As of June 30, 2024 | YoY Change | | :--- | :--- | :--- | :--- | | Total Registered Clients | 464,631 | 459,072 | +1.2% | | Offshore Registered Clients | 18,967 | 16,786 | +13.0% | | Total Active Clients (Q2) | 9,160 | 8,634 | +6.1% | | Offshore Active Clients (Q2) | 3,650 | 3,244 | +12.5% | | Total Value of Distributed Investment Products (Q2) | RMB 17.0 billion | RMB 14.4 billion | +17.7% | | Offshore Investment Product Distribution (Q2) | RMB 8.3 billion | RMB 7.9 billion | +5.1% | - Growth in total value of distributed investment products primarily due to a **44.4%** increase in private securities investment fund distribution[14](index=14&type=chunk)[70](index=70&type=chunk) - As of June 30, 2025, total assets under management (AUM) were **RMB 145.1 billion**, a decrease from **RMB 154.0 billion** on June 30, 2024, but offshore AUM increased by **5.9%** to **RMB 41.4 billion**[15](index=15&type=chunk)[72](index=72&type=chunk) [Management Commentary](index=5&type=section&id=%E7%AE%A1%E7%90%86%E5%B1%A4%E8%A9%95%E8%AB%96) [Chairperson's Statement](index=5&type=section&id=%E8%91%A3%E4%BA%8B%E9%95%B7%E8%87%B4%E8%BE%AD) Ms. Wang Jingbo, Co-founder and Chairperson of Noah Holdings, stated the company is steadily progressing amidst challenges, showing recovery in profitability and revenue, with significant growth in operating income and non-GAAP net profit - Operating income grew robustly by **20.2%** year-over-year, and non-GAAP net profit surged by **78.2%** year-over-year[19](index=19&type=chunk) - Offshore revenue continued to grow, now accounting for nearly **50%** of total net revenue, solidifying the effectiveness of the global expansion strategy[19](index=19&type=chunk) - The company will continue to steadfastly execute its strategy to drive long-term sustainable business growth while prudently observing the market environment[19](index=19&type=chunk) [Q2 2025 Detailed Financial Performance](index=5&type=section&id=2025%E5%B9%B4%E7%AC%AC%E4%BA%8C%E5%AD%A3%E5%BA%A6%E8%A9%B3%E7%B4%B0%E8%B2%A1%E5%8B%99%E6%A5%AD%E7%B8%BE) [Net Revenue Analysis](index=5&type=section&id=%E6%B7%A8%E6%94%B6%E5%85%A5%E5%88%86%E6%9E%90) Q2 2025 net revenue was RMB 629.5 million, up 2.2% year-over-year, mainly driven by increased distribution of offshore and onshore private securities investment funds, with offshore protection and legacy services showing the fastest growth Q2 2025 Net Revenue by Segment | Segment | Q2 2025 (RMB million) | Q2 2024 (RMB million) | YoY Change | | :--- | :--- | :--- | :--- | | Onshore Public Market Securities | 131.8 | 116.8 | +12.8% | | Onshore Asset Management | 177.1 | 198.1 | -10.6% | | Onshore Insurance | 7.2 | 11.7 | -38.7% | | Offshore Wealth Management | 129.4 | 150.6 | -14.1% | | Offshore Asset Management | 108.3 | 97.1 | +11.5% | | Offshore Protection and Legacy Services | 59.0 | 30.9 | +90.9% | | Headquarters | 16.7 | 10.6 | +57.3% | | **Total Net Revenue** | **629.5** | **615.8** | **+2.2%** | - Net revenue from offshore protection and legacy services increased by **90.9%** year-over-year, primarily due to increased distribution fees from offshore insurance products by commission-based brokers[22](index=22&type=chunk) - Net revenue from onshore asset management decreased by **10.6%** year-over-year, mainly due to reduced management fees and performance-based compensation from private equity products[22](index=22&type=chunk) [Operating Costs and Expenses Analysis](index=6&type=section&id=%E7%B6%93%E7%87%9F%E6%88%90%E6%9C%AC%E5%8F%8A%E9%96%8B%E6%94%AF%E5%88%86%E6%9E%90) Total operating costs and expenses in Q2 2025 were RMB 468.5 million, a 2.8% year-over-year decrease, with key components including compensation and benefits, selling expenses, and general and administrative expenses, showing varied changes across segments Q2 2025 Operating Costs and Expenses Breakdown | Item | Amount (RMB million) | Percentage | YoY Change | | :--- | :--- | :--- | :--- | | Compensation and Benefits | 299.3 | 63.9% | +0.8% | | Selling Expenses | 62.3 | 13.3% | +0.7% | | General and Administrative Expenses | 71.2 | 15.2% | -10.9% | | Provision for Credit Losses | 41.2 | 8.8% | N/A | | Other Operating Expenses | 8.6 | 1.8% | -81.4% | | Government Subsidies (Income) | (14.1) | -3.0% | +434.4% | | **Total** | **468.5** | **100.0%** | **-2.8%** | - Operating costs and expenses for onshore public market securities decreased by **57.4%**, mainly due to reduced financial advisor compensation and increased government subsidies[24](index=24&type=chunk) - Headquarters operating costs and expenses increased by **58.9%**, primarily due to increased provision for credit losses related to the suspension of lending business[24](index=24&type=chunk) [Operating Income (Loss)](index=7&type=section&id=%E7%B6%93%E7%87%9F%E6%89%80%E5%BE%97%E6%94%B6%E7%9B%8A%EF%BC%88%E6%90%8D%E5%A4%B1%EF%BC%89) Total operating income in Q2 2025 was RMB 161.0 million, a 20.2% year-over-year increase, with significant growth in onshore public market securities and onshore asset management, and offshore protection and legacy services surging by 186.8% Q2 2025 Operating Income (Loss) by Segment | Segment | Q2 2025 (RMB million) | Q2 2024 (RMB million) | YoY Change | | :--- | :--- | :--- | :--- | | Onshore Public Market Securities | 107.8 | 60.7 | +77.8% | | Onshore Asset Management | 155.1 | 118.4 | +31.0% | | Onshore Insurance | (7.6) | (25.6) | -70.2% | | Offshore Wealth Management | 27.8 | 37.1 | -25.1% | | Offshore Asset Management | 72.6 | 74.2 | -2.1% | | Offshore Protection and Legacy Services | 29.8 | 10.4 | +186.8% | | Headquarters | (224.5) | (141.2) | +59.1% | | **Total Operating Income** | **161.0** | **134.0** | **+20.2%** | - Operating loss from onshore insurance decreased by **70.2%** year-over-year, indicating a narrowing of business losses[25](index=25&type=chunk) [Other Financial Metrics](index=8&type=section&id=%E5%85%B6%E4%BB%96%E8%B2%A1%E5%8B%99%E6%8C%87%E6%A8%99) In Q2 2025, operating margin improved to 25.6%, net profit margin reached 28.4%, interest income decreased by 21.3% year-over-year, investments shifted from gain to loss, and income tax expense increased by 58.2% due to higher withholding tax on dividends in mainland China Q2 2025 Other Financial Metrics | Metric | Q2 2025 | Q2 2024 | YoY Change | | :--- | :--- | :--- | :--- | | Operating Margin | 25.6% | 21.8% | +3.8 percentage points | | Net Profit Margin | 28.4% | 16.8% | +11.6 percentage points | | Interest Income | RMB 33.5 million | RMB 42.6 million | -21.3% | | Investment Gain (Loss) | (RMB 13.9 million) | RMB 10.4 million | Shift from gain to loss | | Income Tax Expense | RMB 63.7 million | RMB 40.3 million | +58.2% | - Investment loss primarily due to unrealized losses from fair value changes in equity investments[28](index=28&type=chunk) [Net Income and Earnings Per Share](index=8&type=section&id=%E6%B7%A8%E6%94%B6%E7%9B%8A%E8%88%87%E6%AF%8F%E8%82%A1%E6%94%B6%E7%9B%8A) In Q2 2025, net income increased by 72.2% year-over-year to RMB 178.5 million, with net income attributable to Noah shareholders growing by 79.0%, and non-GAAP net income attributable to Noah shareholders rising by 78.2% to RMB 189.0 million Q2 2025 Net Income and Earnings Per Share | Metric | Q2 2025 | Q2 2024 | YoY Change | | :--- | :--- | :--- | :--- | | Net Income | RMB 178.5 million | RMB 103.7 million | +72.2% | | Net Income Attributable to Noah Shareholders | RMB 178.6 million | RMB 99.8 million | +79.0% | | Basic Net Income Per ADS | RMB 2.56 | RMB 1.42 | +80.3% | | Diluted Net Income Per ADS | RMB 2.54 | RMB 1.42 | +78.9% | | Non-GAAP Net Income Attributable to Noah Shareholders | RMB 189.0 million | RMB 106.1 million | +78.2% | | Non-GAAP Diluted Net Income Per ADS | RMB 2.69 | RMB 1.51 | +78.1% | [Balance Sheet and Cash Flow](index=8&type=section&id=%E8%B3%87%E7%94%A2%E8%B2%A0%E5%80%B5%E8%A1%A8%E8%88%87%E7%8F%BE%E9%87%91%E6%B5%81%E9%87%8F) [Key Metrics](index=8&type=section&id=%E9%97%9C%E9%8D%B5%E6%8C%87%E6%A8%99) As of June 30, 2025, cash and cash equivalents were RMB 3,821.8 million, a decrease from the previous quarter and prior year, with net cash inflow from operating activities at RMB 27.6 million, reduced net cash outflow from investing activities, and increased net cash outflow from financing activities due to share repurchases Cash and Cash Flow at Q2 2025 End | Metric | As of June 30, 2025 (RMB million) | As of March 31, 2025 (RMB million) | As of June 30, 2024 (RMB million) | | :--- | :--- | :--- | :--- | | Cash and Cash Equivalents | 3,821.8 | 4,075.4 | 4,604.9 | | Net Cash Inflow from Operating Activities (Q2) | 27.6 | - | 49.7 | | Net Cash Outflow from Investing Activities (Q2) | 171.7 | - | 548.2 | | Net Cash Outflow from Financing Activities (Q2) | 71.5 | - | 44.6 | - Net cash inflow from operating activities decreased, primarily due to reduced redemption of trading debt securities in Q2 2025[34](index=34&type=chunk) - Net cash outflow from investing activities decreased, primarily due to reduced purchases of held-to-maturity investments[34](index=34&type=chunk) - Net cash outflow from financing activities increased, primarily due to share repurchases[34](index=34&type=chunk) [Appendix](index=9&type=section&id=%E9%99%84%E9%8C%84) [Conference Call Information](index=9&type=section&id=%E9%9B%BB%E8%A9%B1%E6%9C%83%E8%AD%B0%E4%BF%A1%E6%81%AF) Noah Holdings will host a conference call on Wednesday, August 27, 2025, at 8:00 PM U.S. Eastern Time (Thursday, August 28, 2025, at 8:00 AM Hong Kong Time) to discuss Q2 2025 unaudited financial results and recent business activities - The conference call will be held on August 27, 2025, at 8 PM U.S. Eastern Time, with English and Chinese services available[36](index=36&type=chunk) - A replay of the conference call and webcast recording will be available on the company's investor relations website[36](index=36&type=chunk) [Explanation of Non-GAAP Measures](index=9&type=section&id=%E9%9D%9E%E5%85%AC%E8%AA%8D%E6%9C%83%E8%A8%88%E6%BA%96%E5%89%87%E8%A1%A1%E9%87%8F%E6%A8%99%E6%BA%96%E8%AA%AA%E6%98%8E) The company discloses non-GAAP financial measures to exclude share-based compensation, non-cash settlement expenses, and related tax impacts, supplementing US GAAP data to provide investors with a more comprehensive view of operating performance trends - Non-GAAP measures exclude share-based compensation, non-cash settlement expenses or reversals, and related tax impacts[37](index=37&type=chunk) - These non-GAAP measures should not be considered as substitutes for financial measures prepared in accordance with US GAAP[39](index=39&type=chunk) [About Noah Holdings Limited](index=10&type=section&id=%E9%97%9C%E6%96%BC%E8%AB%BE%E4%BA%9E%E6%8E%A7%E8%82%A1%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8) Noah Holdings Limited is a leading wealth management service provider, offering one-stop advisory services to high-net-worth Chinese investors globally, listed on NYSE and HKEX, with operations spanning wealth and asset management across major Chinese cities and global financial centers - Noah Holdings Limited is listed on the New York Stock Exchange (NOAH) and the Hong Kong Stock Exchange (6686)[40](index=40&type=chunk) - As of June 30, 2025, Noah managed assets totaling **RMB 145.1 billion** and had **464,631** registered clients[40](index=40&type=chunk)[41](index=41&type=chunk) [Foreign Currency Translation Explanation](index=10&type=section&id=%E5%A4%96%E5%B9%A3%E6%8F%9B%E7%AE%97%E8%AA%AA%E6%98%8E) All RMB to USD conversions in this announcement are made at an exchange rate of RMB 7.1636 to USD 1.00, which is the effective noon buying rate on June 30, 2025, as specified in the Federal Reserve Board's H.10 statistical release - The RMB to USD exchange rate is **RMB 7.1636 to USD 1.00**[43](index=43&type=chunk) [Safe Harbor Statement](index=10&type=section&id=%E5%AE%89%E5%85%A8%E6%B8%AF%E8%81%B2%E6%98%8E) This announcement contains forward-looking statements subject to inherent risks and uncertainties, where actual results may differ materially from expectations, and the company undertakes no obligation to update such statements - Forward-looking statements involve inherent risks and uncertainties, and actual results may differ materially from those contemplated in any forward-looking statement[44](index=44&type=chunk)[45](index=45&type=chunk) - The company undertakes no obligation to update any such information as a result of new information, future events, or otherwise[45](index=45&type=chunk) [Contact Information](index=11&type=section&id=%E8%81%AF%E7%B9%AB%E6%96%B9%E5%BC%8F) Provides contact information for Noah Holdings Limited Investor Relations - Contact: Rick Chan, Phone: +86-21-8035-8292, Email: ir@noahgroup.com[46](index=46&type=chunk) [Financial Statements Appendix](index=11&type=section&id=%E8%B2%A1%E5%8B%99%E5%A0%B1%E8%A1%A8%E9%99%84%E9%8C%84) This appendix includes Noah Holdings Limited's condensed consolidated balance sheets, condensed consolidated statements of operations, condensed consolidated statements of comprehensive income, segment condensed statements of operations, additional business data, supplementary revenue data by geographic region and product type, and reconciliation of GAAP to non-GAAP results as of June 30, 2025 - Includes condensed consolidated balance sheets, condensed consolidated statements of operations, and condensed consolidated statements of comprehensive income[47](index=47&type=chunk)[50](index=50&type=chunk)[55](index=55&type=chunk) - Includes segment condensed statements of operations, additional business data, and supplementary revenue data (by geographic region and product type)[57](index=57&type=chunk)[61](index=61&type=chunk)[65](index=65&type=chunk)[67](index=67&type=chunk) - Includes reconciliation of GAAP to non-GAAP results[73](index=73&type=chunk)[75](index=75&type=chunk)

[Unaudited Interim Results Overview](index=1&type=section&id=Unaudited%20Interim%20Results%20Overview) The company achieved a profit for the period, significantly improving from a loss in the prior year, despite a decrease in revenue, while strengthening its financial position [Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income](index=1&type=section&id=Condensed%20Consolidated%20Statement%20of%20Profit%20or%20Loss%20and%20Other%20Comprehensive%20Income) For the six months ended June 30, 2025, the company achieved a profit of HKD 1,418 thousand, a significant improvement from a loss of HKD 28,663 thousand in the prior year, with revenue decreasing by 16.2% but gross profit margin remaining stable at 32.4% Key Data from Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income | Indicator | Six Months Ended June 30, 2025 (HKD thousands) | Six Months Ended June 30, 2024 (HKD thousands) | Change | | :--- | :--- | :--- | :--- | | Revenue | 51,060 | 60,932 | -16.2% | | Cost of sales | (34,527) | (41,271) | -16.3% | | Gross profit | 16,533 | 19,661 | -16.0% | | Other income, gains and losses, net | 12,022 | (5,432) | Turnaround to profit | | Selling and distribution expenses | (14,066) | (14,779) | -4.8% | | General and administrative expenses | (7,860) | (18,069) | -56.5% | | Finance costs | (6,768) | (4,658) | +45.3% | | Reversal of expected credit losses / (impairment losses), net | 3,115 | (5,557) | Turnaround to profit | | Impairment loss on right-of-use assets | (1,444) | – | New | | Profit / (loss) before income tax | 1,532 | (28,834) | Turnaround to profit | | Income tax (expense) / credit | (114) | 171 | Turned to expense | | Profit / (loss) for the period | 1,418 | (28,663) | Turnaround to profit | | Basic and diluted earnings / (loss) per share | 0.18 HKD cents | (3.72) HKD cents | Turnaround to profit | [Condensed Consolidated Statement of Financial Position](index=3&type=section&id=Condensed%20Consolidated%20Statement%20of%20Financial%20Position) As of June 30, 2025, the Group's net current assets increased to HKD 43,930 thousand, with total assets less current liabilities rising to HKD 54,025 thousand, indicating an improved net liability position and capital deficit Key Data from Condensed Consolidated Statement of Financial Position | Indicator | June 30, 2025 (HKD thousands) | December 31, 2024 (HKD thousands) | Change | | :--- | :--- | :--- | :--- | | Non-current assets | 10,095 | 8,796 | +14.8% | | Current assets | 100,807 | 113,250 | -11.0% | | Current liabilities | 56,877 | 72,998 | -22.1% | | Net current assets | 43,930 | 40,252 | +9.1% | | Total assets less current liabilities | 54,025 | 49,048 | +10.1% | | Non-current liabilities | 70,986 | 67,428 | +5.3% | | Net liabilities | (16,961) | (18,380) | Decreased by 8.0% | | Share capital | 7,705 | 7,705 | 0% | | Reserves | (24,666) | (26,085) | Decreased by 5.4% | | Capital deficit | (16,961) | (18,380) | Decreased by 8.0% | [Notes to the Unaudited Condensed Consolidated Interim Financial Statements](index=5&type=section&id=Notes%20to%20the%20Unaudited%20Condensed%20Consolidated%20Interim%20Financial%20Statements) This section details the accounting policies, significant judgments, and specific financial statement items, providing context for the interim financial results [Basis of Preparation and Going Concern](index=5&type=section&id=Basis%20of%20Preparation%20and%20Going%20Concern) The financial statements are prepared in accordance with HKAS 34 and Appendix D2 of the Listing Rules, presented in HKD, with the Board affirming the Group's ability to continue as a going concern despite net liabilities - The Group had **net liabilities of HKD 16,961 thousand** as of June 30, 2025[9](index=9&type=chunk) - The Board has thoroughly reviewed cash flow forecasts covering a period of no less than **12 months** into the future[9](index=9&type=chunk) - To improve its financial position, the Board is implementing measures including actively recovering loans receivable, considering the realization of financial assets at fair value through profit or loss, and implementing aggressive cost-saving initiatives[10](index=10&type=chunk) - The Board considers it appropriate to prepare the financial statements on a going concern basis[11](index=11&type=chunk) [Principal Accounting Policies and Judgements](index=6&type=section&id=Principal%20Accounting%20Policies%20and%20Judgements) The financial statements are prepared on a historical cost basis, with certain financial instruments measured at fair value, and the application of new HKFRS amendments had no significant impact - The financial statements are prepared on a historical cost basis, except for certain financial instruments measured at fair value[12](index=12&type=chunk) - Amendments to Hong Kong Financial Reporting Standards (e.g., HKAS 21 and HKFRS 1 amendments) were first applied during the period but had no significant impact[13](index=13&type=chunk) - Significant judgments and sources of estimation uncertainty made by management in preparing the statements are consistent with those in the 2024 annual financial statements[14](index=14&type=chunk) [Revenue, Other Income, Gains and Losses, Net and Segment Information](index=7&type=section&id=Revenue%2C%20Other%20Income%2C%20Gains%20and%20Losses%2C%20Net%20and%20Segment%20Information) The Group's total revenue for the period was HKD 51,060 thousand, a 16.2% decrease year-on-year, primarily from Chinese herbal health products, money lending, and investment in financial instruments, with the latter achieving significant profit - The Group's principal businesses are the sale of Chinese herbal health products, money lending, and investment in financial instruments[15](index=15&type=chunk) Revenue Composition (HKD thousands) | Revenue Source | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | Change | | :--- | :--- | :--- | :--- | | Revenue from contracts with customers - Trading of Chinese herbal health products | 50,975 | 60,426 | -15.6% | | Interest income | 323 | 611 | -47.1% | | Loss on disposal of financial instruments, net | (238) | (105) | +126.7% | | **Total Revenue** | **51,060** | **60,932** | **-16.2%** | - Other income, gains and losses, net: primarily fair value gains on financial assets at fair value through profit or loss of **HKD 12,410 thousand** (2024: loss of HKD 5,431 thousand)[15](index=15&type=chunk) [Segment Revenue and Results](index=8&type=section&id=Segment%20Revenue%20and%20Results) This section details the revenue and pre-tax profit or loss for each operating segment, including Chinese herbal health products, money lending, and investment in financial instruments Segment Revenue and Profit/(Loss) Before Income Tax (HKD thousands) | Segment | Six Months Ended June 30, 2025 Revenue | Six Months Ended June 30, 2025 Profit/(Loss) | Six Months Ended June 30, 2024 Revenue | Six Months Ended June 30, 2024 Profit/(Loss) | | :--- | :--- | :--- | :--- | :--- | | Chinese Herbal Health Products | 50,975 | (4,399) | 60,426 | (1,996) | | Money Lending Business | 323 | 869 | 611 | (13,739) | | Investment in Financial Instruments | (238) | 11,369 | (105) | (6,415) | | **Total Reportable Segments** | **51,060** | **7,839** | **60,932** | **(22,150)** | - Company revenue and expenses are not included in the segment profit/(loss) measure used by the chief operating decision maker to assess segment performance[16](index=16&type=chunk) [Segment Assets and Liabilities](index=9&type=section&id=Segment%20Assets%20and%20Liabilities) This section presents the breakdown of assets and liabilities by operating segment, showing changes in each segment's financial position Segment Assets (HKD thousands) | Segment | June 30, 2025 | December 31, 2024 | Change | | :--- | :--- | :--- | :--- | | Chinese Herbal Health Products | 55,349 | 75,206 | -26.4% | | Money Lending Business | 10,177 | 8,760 | +16.2% | | Investment in Financial Instruments | 43,520 | 35,591 | +22.3% | | **Total Segment Assets** | **109,046** | **119,557** | **-8.8%** | Segment Liabilities (HKD thousands) | Segment | June 30, 2025 | December 31, 2024 | Change | | :--- | :--- | :--- | :--- | | Chinese Herbal Health Products | 34,154 | 45,314 | -24.6% | | Money Lending Business | 2,570 | 806 | +218.9% | | Investment in Financial Instruments | 18,295 | 20,586 | -11.2% | | **Total Segment Liabilities** | **55,019** | **66,706** | **-17.5%** | [Geographical Information](index=10&type=section&id=Geographical%20Information) This section provides a geographical breakdown of the Group's revenue, indicating the primary regions contributing to sales Revenue by Geographical Area (HKD thousands) | Region | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | | Hong Kong | 51,060 | 60,932 | [Major Customers Information](index=10&type=section&id=Major%20Customers%20Information) This section discloses information regarding the Group's major customers, specifically whether any single external customer contributes 10% or more to total revenue - For the six months ended June 30, 2025 and 2024, no external customer contributed **10% or more** to the Group's revenue[22](index=22&type=chunk) [Finance Costs](index=11&type=section&id=Finance%20Costs) For the six months ended June 30, 2025, the Group's finance costs increased to HKD 6,768 thousand, primarily due to higher interest on bonds issued in 2024 Finance Costs (HKD thousands) | Type of Finance Cost | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | Change | | :--- | :--- | :--- | :--- | | Interest on borrowings | 1,692 | 1,535 | +10.2% | | Interest on lease liabilities | 347 | 334 | +3.9% | | Interest on convertible loan notes | 1,061 | 2,789 | -62.0% | | Interest on bonds payable | 3,668 | – | New | | **Total** | **6,768** | **4,658** | **+45.3%** | [Income Tax (Expense)/Credit](index=11&type=section&id=Income%20Tax%20%28Expense%29%2FCredit) For the six months ended June 30, 2025, the Group recorded an income tax expense of HKD 114 thousand, a shift from a credit of HKD 171 thousand in the prior year, with no tax provision for Hong Kong or PRC subsidiaries due to lack of taxable profit - Income tax (expense)/credit: **HKD (114) thousand** expense in 2025, compared to **HKD 171 thousand** credit in 2024[23](index=23&type=chunk) - Hong Kong subsidiaries did not generate taxable profits, so no Hong Kong profits tax provision was made[23](index=23&type=chunk) - PRC subsidiaries did not generate taxable profits, so no enterprise income tax provision was made[24](index=24&type=chunk) [Profit/(Loss) for the Period](index=12&type=section&id=Profit%2F%28Loss%29%20for%20the%20Period) The Group's profit for the period was influenced by factors such as cost of goods sold, depreciation, and staff costs Profit/(Loss) for the Period Components (HKD thousands) | Item | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | | Cost of goods sold | 31,666 | 41,271 | | Depreciation of right-of-use assets | 2,975 | 3,357 | | Depreciation of property, plant and equipment | 183 | 132 | | Staff costs (including directors' emoluments) | 11,936 | 21,743 | [Dividends](index=12&type=section&id=Dividends) The Board does not recommend the payment of an interim dividend for the six months ended June 30, 2025 - No interim dividend is recommended for the first half of 2025[27](index=27&type=chunk) [Earnings/(Loss) Per Share](index=12&type=section&id=Earnings%2F%28Loss%29%20Per%20Share) For the six months ended June 30, 2025, basic and diluted earnings per share were HKD 0.18 cents, a significant improvement from a loss of HKD 3.72 cents in the prior year, primarily due to the period's profit Earnings/(Loss) Per Share Calculation Data (HKD thousands) | Indicator | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | | Profit/(loss) for the purpose of calculating basic and diluted earnings/(loss) per share | 1,418 | (28,663) | | Weighted average number of ordinary shares | 770,480,836 | 770,480,836 | - The convertible loan notes were not assumed to be converted for calculating diluted earnings/(loss) per share, as they would result in an increase/decrease in earnings/(loss) per share[30](index=30&type=chunk) [Property, Plant and Equipment and Right-of-use Assets](index=13&type=section&id=Property%2C%20Plant%20and%20Equipment%20and%20Right-of-use%20Assets) For the six months ended June 30, 2025, the Group acquired property, plant and equipment costing HKD 84 thousand and recognized additional right-of-use assets of approximately HKD 5,948 thousand, with an impairment loss of HKD 1,444 thousand recognized for right-of-use assets due to loss-making stores - Cost of property, plant and equipment acquired: **HKD 84 thousand** (2024: HKD 141 thousand)[31](index=31&type=chunk) - Additional right-of-use assets recognized: **HKD 5,948 thousand** (2024: HKD 1,552 thousand), primarily for retail stores and office leases in Hong Kong[31](index=31&type=chunk) - Impairment loss on right-of-use assets recognized: **HKD 1,444 thousand** (2024: nil), mainly due to certain loss-making stores in the Chinese herbal health products segment[34](index=34&type=chunk) - Impairment assessment was based on the value-in-use calculation of cash-generating units, using a five-year financial budget and a pre-tax discount rate of **14%**[33](index=33&type=chunk) [Loans Receivable](index=14&type=section&id=Loans%20Receivable) As of June 30, 2025, net loans receivable from the money lending business increased to HKD 10,139 thousand, with all loans unsecured and bearing interest rates between 8% and 13%, including a significant loan to a major shareholder's ultimate holding company Loans Receivable (HKD thousands) | Indicator | June 30, 2025 | December 31, 2024 | Change | | :--- | :--- | :--- | :--- | | Gross loans receivable from money lending business | 307,111 | 308,655 | -0.5% | | Less: Net provision for expected credit losses | (296,972) | (300,087) | -1.0% | | **Net Loans Receivable** | **10,139** | **8,568** | **+18.3%** | - All loans are unsecured, with annual interest rates ranging from **8% to 13%**[35](index=35&type=chunk) - Loans receivable include a **HKD 6,268 thousand** loan to the ultimate holding company of a major shareholder[35](index=35&type=chunk) Loans Receivable Maturity Profile (HKD thousands) | Maturity Date | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | Within one year | 9,609 | 7,719 | | Over one year | 530 | 849 | [Financial Assets at Fair Value Through Profit or Loss](index=14&type=section&id=Financial%20Assets%20at%20Fair%20Value%20Through%20Profit%20or%20Loss) As of June 30, 2025, total financial assets at fair value through profit or loss increased to HKD 43,520 thousand, primarily comprising Hong Kong-listed equity securities Financial Assets at Fair Value Through Profit or Loss (HKD thousands) | Type | June 30, 2025 | December 31, 2024 | Change | | :--- | :--- | :--- | :--- | | Listed equity securities in Hong Kong — Current | 42,807 | 35,015 | +22.2% | | Unlisted equity securities — Non-current | 713 | 576 | +23.8% | | **Total** | **43,520** | **35,591** | **+22.3%** | - The fair value of listed equity securities is determined based on quotations from the Stock Exchange, while unlisted equity securities are valued using the asset-based approach[36](index=36&type=chunk) [Trade and Other Receivables, Deposits and Prepayments](index=15&type=section&id=Trade%20and%20Other%20Receivables%2C%20Deposits%20and%20Prepayments) As of June 30, 2025, total trade and other receivables, deposits, and prepayments decreased to HKD 6,550 thousand, mainly due to a reduction in trade receivables Trade and Other Receivables, Deposits and Prepayments (HKD thousands) | Item | June 30, 2025 | December 31, 2024 | Change | | :--- | :--- | :--- | :--- | | Trade receivables (net of allowance) | 1,595 | 4,064 | -60.7% | | Deposits and other receivables | 3,247 | 3,434 | -5.4% | | Prepayments | 1,708 | 1,347 | +26.8% | | **Total** | **6,550** | **8,845** | **-26.0%** | - Trade receivables aging analysis: **HKD 1,591 thousand** for 0-90 days, and **HKD 4 thousand** for over 365 days[37](index=37&type=chunk) - The normal credit period ranges from **30 to 90 days**[37](index=37&type=chunk) [Trade and Other Payables and Accruals](index=15&type=section&id=Trade%20and%20Other%20Payables%20and%20Accruals) As of June 30, 2025, total trade and other payables and accruals significantly decreased to HKD 16,622 thousand, primarily driven by a substantial reduction in trade payables Trade and Other Payables and Accruals (HKD thousands) | Item | June 30, 2025 | December 31, 2024 | Change | | :--- | :--- | :--- | :--- | | Trade payables | 4,486 | 18,069 | -75.2% | | Other payables and accruals | 12,136 | 15,421 | -21.3% | | **Total** | **16,622** | **33,490** | **-50.3%** | - Trade payables aging analysis: **HKD 4,347 thousand** for 0-90 days, and **HKD 139 thousand** for over 365 days[39](index=39&type=chunk) [Borrowings](index=16&type=section&id=Borrowings) As of June 30, 2025, the Group's total borrowings were HKD 32,391 thousand, slightly lower than December 31, 2024, primarily consisting of margin loans from securities brokers and other loans, all classified as current liabilities Borrowings (HKD thousands) | Type | June 30, 2025 | December 31, 2024 | Change | | :--- | :--- | :--- | :--- | | Margin loans from securities brokers | 16,581 | 18,872 | -12.1% | | Other loans | 15,810 | 13,700 | +15.4% | | **Total** | **32,391** | **32,572** | **-0.6%** | - Margin loans bear interest at **8%-10% per annum** and are secured by a portfolio of listed equity securities valued at **HKD 42,807 thousand**[39](index=39&type=chunk) - Other loans bear interest at **12% per annum**, are secured by a share charge over issued shares of a subsidiary, and guaranteed by the Company[40](index=40&type=chunk) - All borrowings are classified as current liabilities due to the inclusion of a repayment on demand clause[40](index=40&type=chunk) [Share Capital](index=17&type=section&id=Share%20Capital) As of June 30, 2025, the company's issued and fully paid share capital remained unchanged at HKD 7,705 thousand, comprising 770,481 thousand ordinary shares with a par value of HKD 0.01 each - Issued and fully paid ordinary shares: **770,481 thousand shares**, par value **HKD 0.01 per share**, totaling **HKD 7,705 thousand**[42](index=42&type=chunk) - Authorized share capital includes **USD 40 thousand** in convertible redeemable cumulative preference shares with a par value of USD 100,000 per share, and **150,000,000 thousand** ordinary shares with a par value of HKD 0.01 per share[42](index=42&type=chunk) [Share Option Scheme](index=17&type=section&id=Share%20Option%20Scheme) The Group adopted a new share option scheme on August 15, 2024, to recognize contributions from eligible participants, with a total of 77,048,083 options available for grant, representing 10% of issued shares, and no options were granted or exercised during the period - The 2012 Share Option Scheme expired on September 14, 2022, with no outstanding options as of June 30, 2025[41](index=41&type=chunk) - A new share option scheme was adopted on **August 15, 2024**, to acknowledge and recognize contributions from eligible participants to the Group[43](index=43&type=chunk) - Eligible participants include directors, employees, suppliers, contractors, distributors, agents, consultants, and advisors[43](index=43&type=chunk) - The total number of options available for grant under the new scheme is **77,048,083**, representing **10%** of the issued shares[43](index=43&type=chunk)[44](index=44&type=chunk) - Maximum entitlement for each participant: the total number of shares after exercise shall not exceed **1%** of the issued shares within any 12-month period[44](index=44&type=chunk) - Grants to a substantial shareholder or independent non-executive director and their associates exceeding **0.1%** require shareholder approval[45](index=45&type=chunk) - The exercise period for share options is determined by the Board, not exceeding **ten years** from the date of grant[46](index=46&type=chunk) - Grantees must hold the options for at least **12 months** before they can be exercised[46](index=46&type=chunk) - The exercise price shall not be less than the highest of the closing price on the grant date, the average closing price for the preceding five days, and the nominal value[46](index=46&type=chunk) - The new share option scheme will terminate on **August 15, 2034**[46](index=46&type=chunk) - As of June 30, 2025, no share options were granted, exercised, lapsed, or cancelled under the new scheme[47](index=47&type=chunk) [Contingent Liabilities](index=19&type=section&id=Contingent%20Liabilities) As of June 30, 2025, and December 31, 2024, the Group had no contingent liabilities - The Group had no contingent liabilities at the end of the reporting period[48](index=48&type=chunk) [Related Party Transactions](index=20&type=section&id=Related%20Party%20Transactions) For the six months ended June 30, 2025, the Group with related parties (primarily the ultimate holding company of a major shareholder) engaged in short-term lease expenses and interest income transactions, and maintained outstanding loan balances Related Party Transactions (HKD thousands) | Type of Transaction | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :--- | :--- | :--- | | Short-term lease expenses | 180 | 796 | | Interest income | 270 | 380 | Related Party Balances (HKD thousands) | Type of Balance | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | Loans receivable (ultimate holding company of a major shareholder) | 6,268 | 7,092 | [Comparative Figures](index=20&type=section&id=Comparative%20Figures) Certain comparative figures have been reclassified to ensure consistency with the current period's presentation - Some comparative figures have been reclassified for consistency[51](index=51&type=chunk) [Management Discussion and Analysis](index=21&type=section&id=Management%20Discussion%20and%20Analysis) This section provides an in-depth review of the Group's financial performance, business operations, and future outlook, including strategies for growth and risk management [Interim Dividend](index=21&type=section&id=Interim%20Dividend) The Board does not recommend the payment of an interim dividend for the six months ended June 30, 2025 - No interim dividend is recommended for the first half of 2025[52](index=52&type=chunk) [Results, Business Review and Prospects](index=21&type=section&id=Results%2C%20Business%20Review%20and%20Prospects) The Group's revenue declined due to reduced contributions from Chinese herbal health products and money lending, but effective cost control, expected credit loss reversals, and fair value gains on financial assets led to a turnaround to profit [Results Overview](index=21&type=section&id=Results%20Overview) This section provides a high-level summary of the Group's financial performance, highlighting key changes in revenue, gross profit margin, and profit attributable to owners - Revenue decreased by approximately **16%** year-on-year to approximately **HKD 51 million**[53](index=53&type=chunk) - Gross profit margin remained stable at approximately **32%**[53](index=53&type=chunk) - Profit attributable to owners was approximately **HKD 1 million**, compared to a loss of approximately **HKD 29 million** in the prior year[53](index=53&type=chunk) [Business Review](index=21&type=section&id=Business%20Review) This section reviews the performance of the Group's core business segments, including Chinese herbal health products, money lending, and investment in financial instruments - Revenue decreased by approximately **16%**, primarily due to reduced revenue from Chinese herbal health products (from approximately **HKD 60 million** to approximately **HKD 51 million**) and money lending business (from approximately **HKD 1 million** to approximately **HKD 0.3 million**)[54](index=54&type=chunk) - Gross profit margin remained stable at approximately **32%**[54](index=54&type=chunk) - Other income, gains and losses, net, turned from a loss of **HKD 5 million** in 2024 to a net gain of **HKD 12 million** in 2025, mainly from fair value gains on financial assets[55](index=55&type=chunk) - Selling and distribution expenses remained stable at approximately **HKD 14 million**, reflecting effective cost control measures[55](index=55&type=chunk) - General and administrative expenses significantly decreased by **56.5%** to approximately **HKD 8 million**, primarily due to streamlined management team structure and salary adjustments[56](index=56&type=chunk) - Finance costs increased by approximately **45.3%** to approximately **HKD 7 million**, mainly due to changes in the calculation method for bond interest in 2024[57](index=57&type=chunk) - Net reversal of impairment losses under the expected credit loss model was approximately **HKD 3 million**, compared to an impairment loss of approximately **HKD 6 million** in the prior year, reflecting improved customer credit risk and repayment of some impaired loans[58](index=58&type=chunk) - Impairment loss on right-of-use assets was approximately **HKD 1 million**, due to certain loss-making stores in the Chinese herbal health products segment[59](index=59&type=chunk) - The turnaround to profit was primarily driven by the reversal of expected credit losses, a significant reduction in general and administrative expenses, and unrealized fair value gains on financial assets[60](index=60&type=chunk) [Chinese Herbal Health Products](index=23&type=section&id=Chinese%20Herbal%20Health%20Products) The Chinese herbal health products segment experienced a decrease in revenue and an increase in loss due to a challenging retail environment in Hong Kong, despite the "Nam Pei Hong" brand's recognition - Segment revenue was approximately **HKD 51 million** (2024: HKD 60 million), with a segment loss (pre-tax) of approximately **HKD 4 million** (2024: HKD 2 million)[62](index=62&type=chunk) - The decrease in revenue and increase in loss were mainly due to the challenging economic environment in Hong Kong's local retail sector, with consumers being more budget-conscious and tending to spend in mainland China[62](index=62&type=chunk) - The "Nam Pei Hong" brand is widely recognized in Hong Kong and Southern mainland China, with **10 retail stores** as of June 30, 2025[61](index=61&type=chunk) [Money Lending Business](index=23&type=section&id=Money%20Lending%20Business) The money lending business saw a decrease in interest income but achieved a segment profit due to a net reversal of expected credit loss impairment, with ongoing efforts to recover outstanding loans - Loan interest income was approximately **HKD 0.3 million** (2024: HKD 1 million), with a segment profit (pre-tax) of approximately **HKD 1 million** (2024: loss of HKD 14 million)[63](index=63&type=chunk) - The decrease in interest income was mainly because loans receivable previously classified as Stage 3 (credit-impaired) no longer generated interest income[63](index=63&type=chunk) - The segment's turnaround to profit was primarily due to a reduction in impairment losses on loans receivable under the expected credit loss model, with a net reversal of impairment losses of approximately **HKD 3 million** recognized during the period[63](index=63&type=chunk) - No new loans were granted during the period, but the repayment date for a revolving loan of approximately **HKD 9 million** provided to the ultimate holding company of a major shareholder was extended[64](index=64&type=chunk) - Customers repaid approximately **HKD 3 million** in loan principal and interest, while the ultimate holding company of a major shareholder drew down approximately **HKD 1 million**[64](index=64&type=chunk) - As of June 30, 2025, out of **11 outstanding loans**, **2 loans** (approximately **HKD 8 million**) were classified as Stage 1, and **9 loans** (approximately **HKD 299 million**) were classified as Stage 3[65](index=65&type=chunk) - The cumulative net provision for expected credit losses was approximately **HKD 297 million**, a decrease of approximately **HKD 3 million** from December 31, 2024, mainly due to improved credit risk profiles of certain customers and repayment of some impaired loans[67](index=67&type=chunk)[68](index=68&type=chunk) - Customer E has sold properties and parking spaces, with the Group receiving net proceeds of **HKD 3.5 million** and actively pursuing the remaining balance[70](index=70&type=chunk) - Customer I: Discussions are ongoing with a third party to acquire the loans receivable through the transfer of properties in Guangzhou and mainland China[71](index=71&type=chunk) - Customers J, G, F, and K have settled part of their outstanding debts, and the Group is negotiating settlement arrangements[72](index=72&type=chunk)[74](index=74&type=chunk)[76](index=76&type=chunk)[78](index=78&type=chunk) - Customer L entered into a deed of settlement in May 2024 and has partially repaid the amounts in installments[81](index=81&type=chunk) [Investment in Financial Instruments](index=28&type=section&id=Investment%20in%20Financial%20Instruments) The investment in financial instruments segment generated a pre-tax profit, primarily driven by fair value gains on financial assets at fair value through profit or loss, with active portfolio management to enhance performance - Segment gain (pre-tax) was approximately **HKD 11 million** (2024: loss of HKD 6 million)[82](index=82&type=chunk) - Key influencing factors: net fair value gains on financial assets at fair value through profit or loss of approximately **HKD 12 million** (2024: loss of HKD 5 million), and realized losses on disposal of financial assets of approximately **HKD 0.2 million** (2024: HKD 0.1 million)[82](index=82&type=chunk) Equity Investment Changes (HKD thousands) | Item | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | Beginning/End of period | 35,591 | 40,420 | | Acquisitions | – | 1,866 | | Gains/(losses) from fair value changes | 12,410 | (4,187) | | Disposals | (4,481) | (2,508) | | **End/Beginning of period** | **43,520** | **35,591** | - Significant listed equity investments include Huanxi Media Group, Grand Harbour Development, Yunfeng Financial Group, and Geowave Technology Holdings, with Yunfeng Financial Group contributing **HKD 9,008 thousand** in fair value gains[83](index=83&type=chunk) - The Group's investment objective is to achieve capital gains and dividend income, actively adjusting its investment portfolio to enhance performance[83](index=83&type=chunk) [Prospects](index=30&type=section&id=Prospects) This section outlines the future outlook and strategic initiatives for each of the Group's business segments, addressing challenges and opportunities [Chinese Herbal Health Products Prospects](index=30&type=section&id=Chinese%20Herbal%20Health%20Products%20Prospects) The Chinese herbal health products segment faces challenges from a weak retail market and changing consumer behavior, but plans to counter this with product innovation, targeted promotions, strategic partnerships, and stringent cost management - Challenges faced: sluggish retail market, weak consumer sentiment, mainland economic downturn, changing spending patterns of visitors to Hong Kong, local residents' preference for mainland shopping, price competition, customs regulations, labor shortages, and rising operating costs[84](index=84&type=chunk) - Strategies: prioritize promotion of seasonal health products like soup packs, launch trial packs for Lingzhi capsules, Platycodon Grandiflorum soothing throat lozenges, and black and white immune essence extracts, and expand own-brand portable health products[85](index=85&type=chunk) - Marketing: participate in SOGO and YATA VIP day promotions, launch an official account on Xiaohongshu, and introduce "Tuesday Senior Discounts" and member package discount coupons[86](index=86&type=chunk) - Strategic cooperation: partner with MAME LAB to launch pre-natal and post-natal care packages[86](index=86&type=chunk) - Cost management: strengthen overseas procurement, optimize supply chain, strictly control headcount and staff costs, and optimize sales incentive mechanisms[87](index=87&type=chunk) - Future outlook: continue strong promotional activities, launch innovative products and tailored promotional campaigns to maintain and strengthen market position[87](index=87&type=chunk) [Money Lending Business Prospects](index=31&type=section&id=Money%20Lending%20Business%20Prospects) The money lending business anticipates a challenging operating environment due to economic uncertainty, requiring close monitoring of repayment habits, proactive recovery plans, and enhanced credit risk management - Operating environment faces challenges: gloomy economic conditions, cautious potential borrowers, increased default risks, and geopolitical tensions affecting borrower demand[89](index=89&type=chunk) - Strategies: closely monitor customer repayment habits, develop action plans for recovery (revising repayment terms, increasing collateral/guarantees, reaching settlements, legal actions, enforcing collateral/guarantees)[89](index=89&type=chunk) - Strengthen credit policies and risk management[89](index=89&type=chunk) [Investment in Financial Instruments Prospects](index=31&type=section&id=Investment%20in%20Financial%20Instruments%20Prospects) The investment in financial instruments segment will focus on closely monitoring global economic conditions and investment sentiment, actively adjusting its portfolio to improve performance and realize gains - Strategies: closely monitor global economy, investment sentiment, investor base, and future outlook[90](index=90&type=chunk) - Actively adjust investment portfolio to improve performance and realize equity holdings in a timely manner[90](index=90&type=chunk) [Portfolio Management](index=32&type=section&id=Portfolio%20Management) The Group's business strategy aims to optimize resource utilization, enhance overall performance, and diversify its investment portfolio by actively seeking opportunities for investment or acquisition in promising ventures to create shareholder value - Strategy: optimize resource utilization, improve overall performance, and promote portfolio diversification[91](index=91&type=chunk) - Actively seek business opportunities to diversify income sources through investment/acquisition of promising businesses or projects to create shareholder value[91](index=91&type=chunk) [Group Resources and Liquidity](index=32&type=section&id=Group%20Resources%20and%20Liquidity) As of June 30, 2025, the Group had cash and bank balances of approximately HKD 4 million, with total borrowings, convertible loan notes, and bonds payable totaling approximately HKD 97 million, an improved liquidity ratio of 1.8, and a reduced net liability position, affirming sufficient working capital for the next 12 months Resources and Liquidity (HKD thousands) | Indicator | June 30, 2025 | December 31, 2024 | Change | | :--- | :--- | :--- | :--- | | Cash and bank balances | 4,000 | 10,000 | -60.0% | | Total borrowings | 32,000 | 33,000 | -3.0% | | Convertible loan notes | 15,000 | 14,000 | +7.1% | | Bonds payable | 50,000 | 49,000 | +2.0% | | **Total Borrowings, Convertible Loan Notes, and Bonds Payable** | **97,000** | **96,000** | **+1.0%** | - Some financial assets (approximately **HKD 43 million**) have been pledged as collateral for borrowings of approximately **HKD 17 million**[93](index=93&type=chunk) - Approximately **HKD 15 million** in borrowings are secured by a share charge over subsidiary shares and guaranteed by the Company[93](index=93&type=chunk) - All borrowings (HKD 32 million) are classified as current liabilities[94](index=94&type=chunk) - The 2024 bonds (approximately **HKD 55 million** in ordinary bonds and approximately **HKD 17 million** in convertible bonds) were issued to offset the outstanding principal of the 2018 convertible bonds[95](index=95&type=chunk) - Inventories decreased by approximately **28%** to approximately **HKD 36 million**, mainly due to winter being the traditional peak season for the industry[96](index=96&type=chunk) - Trade receivables decreased to approximately **HKD 2 million**, consistent with reduced revenue from Chinese herbal health products and improved collection management[97](index=97&type=chunk) - Trade payables significantly decreased to approximately **HKD 4 million**, due to subsequent settlements and reduced procurement[97](index=97&type=chunk) - Gearing ratio: **88%** (December 31, 2024: **79%**)[98](index=98&type=chunk) - Current ratio: **1.8** (December 31, 2024: **1.6**)[98](index=98&type=chunk) - Net liability position decreased from approximately **HKD 18 million** to approximately **HKD 17 million**, primarily due to operating profit during the period[98](index=98&type=chunk) - The Board believes the Group has sufficient working capital for the next **12 months**[99](index=99&type=chunk) - The Group will continue to review existing businesses, improve operational and financial performance, and identify potential business and investment opportunities[100](index=100&type=chunk) [Foreign Exchange Risk](index=34&type=section&id=Foreign%20Exchange%20Risk) The Group is exposed to currency risk primarily from receivables, payables, and bank balances denominated in non-functional currencies, with management monitoring and considering hedging significant exposures despite no current foreign currency hedging policy - Currency risk primarily arises from receivables/payables and bank balances denominated in non-functional currencies[101](index=101&type=chunk) - There is currently no foreign currency hedging policy, but management will monitor and consider hedging significant risks[101](index=101&type=chunk) [Share Capital Structure](index=34&type=section&id=Share%20Capital%20Structure) There were no changes to the Group's share capital structure during the period - No changes to the share capital structure occurred during the period[102](index=102&type=chunk) [Significant Investments and Acquisitions](index=34&type=section&id=Significant%20Investments%20and%20Acquisitions) The Group did not undertake any significant investments, acquisitions, or disposals of subsidiaries during the period - No significant investments, acquisitions, or disposals of subsidiaries occurred during the period[103](index=103&type=chunk) [Employees](index=34&type=section&id=Employees) As of June 30, 2025, the Group employed approximately 77 staff and contract workers, with staff costs of approximately HKD 12 million, and compensation determined by experience, performance, and market conditions, including discretionary bonuses, MPF, and training - Approximately **77 employees** and contract workers were employed[104](index=104&type=chunk) - Staff costs (including directors' emoluments) were approximately **HKD 12 million** (2024: HKD 22 million)[105](index=105&type=chunk) - Remuneration is determined based on experience, performance, market conditions, industry practices, and applicable labor laws[105](index=105&type=chunk) - Discretionary bonuses, MPF contribution schemes, insurance, and various training programs are provided[105](index=105&type=chunk) [Share Option Scheme](index=35&type=section&id=Share%20Option%20Scheme_MD%26A) The Group's new share option scheme, adopted on August 15, 2024, complies with the requirements of Rule 17.03 of the Listing Rules - The new share option scheme was approved and adopted on **August 15, 2024**, complying with Rule 17.03 of the Listing Rules[106](index=106&type=chunk) - Details are provided in Note 17 to the financial statements[106](index=106&type=chunk) [Purchase, Sale or Redemption of Listed Securities](index=35&type=section&id=Purchase%2C%20Sale%20or%20Redemption%20of%20Listed%20Securities) Neither the company nor its subsidiaries purchased, redeemed, or sold any of the company's listed securities during the six months ended June 30, 2025 - No purchase, redemption, or sale of the company's listed securities occurred during the period[107](index=107&type=chunk) [Contingent Liabilities](index=35&type=section&id=Contingent%20Liabilities_MD%26A) As of June 30, 2025, the Group had no other significant contingent liabilities or guarantees beyond those already disclosed - As of the end of the reporting period, the Group had no other significant contingent liabilities or guarantees[108](index=108&type=chunk) [Corporate Governance Code](index=35&type=section&id=Corporate%20Governance%20Code) The Board confirms that the company has complied with all code provisions of the Corporate Governance Code set out in Appendix C1 of the Listing Rules for the six months ended June 30, 2025 - The company complied with all provisions of the Corporate Governance Code set out in Appendix C1 of the Listing Rules[109](index=109&type=chunk) [Standard Code for Securities Transactions by Directors](index=35&type=section&id=Standard%20Code%20for%20Securities%20Transactions%20by%20Directors) The company has adopted a code of conduct for directors' securities transactions no less exacting than the Standard Code in Appendix C3 of the Listing Rules, and all directors confirmed compliance during the period - The company has adopted a code of conduct for directors' securities transactions, and all directors confirmed compliance[110](index=110&type=chunk) [Audit Committee](index=36&type=section&id=Audit%20Committee) The Audit Committee has reviewed the unaudited condensed consolidated interim financial statements, risk management, and internal control systems for the six months ended June 30, 2025, and concurred with the accounting policies and practices adopted by the company - The Audit Committee reviewed the interim financial statements, risk management, and internal control systems, and concurred with the accounting policies and practices[111](index=111&type=chunk) [By Order of the Board](index=36&type=section&id=By%20Order%20of%20the%20Board) This announcement is issued by Mr. Li Xiongwei, Chairman and Executive Director, on behalf of the Board of Directors - Mr. Li Xiongwei, Chairman and Executive Director, issued the announcement on behalf of the Board[112](index=112&type=chunk) - Executive Directors include Li Xiongwei, Zhang Guowei, Liang Yixi, Lao Mingyun, Yuan Huixia, Yang Qiangsheng; Independent Non-executive Directors include Li Xuejian, Zeng Zhanpeng[113](index=113&type=chunk)

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或因倚賴該等內 容而引致的任何損失承擔任何責任。 CMGE Technology Group Limited 中手游科技集 團 有限公司 （於開曼群島註冊成立的有限公司） （股份代號：0302） 截 至 2025 年 6 月 30 日止六個月 中期業績公告 中手游科技集團有限公司（「本公司」，連同其附屬公司及在中華人民共和國（「中 國」）的合併營運實體，統稱「本集團」）董事（「董事」）會（「董事會」）欣然公佈本集團 截至2025年6月30日止六個月（「報告期間」）的未經審核綜合中期業績。本報告期間 之中期業績已由本公司之審核委員會（「審核委員會」）審閱。 財務摘要 | | 截至6月30日止六個月 | | | --- | --- | --- | | | 2025年 | 2024年 | | | 人民幣千元 | 人民幣千元 | | | （未經審核） | （未經審核） | | 收益 | 763,034 | 1,233,336 | | 期內虧損 | (644,2 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或 任 何 部 分 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任。 China Shuifa Singyes Energy Holdings Limited 中國水發興業能源集團有限公司 （於百慕達註冊成立之有限公司） （股份代號：750） 截至二零二五年六月三十日止六個月的中期業績公告 中 國 水 發 興 業 能 源 集 團 有 限 公 司（「本公司」）董 事（「董 事」）會（統 稱「董事會」）欣 然 宣 佈 本 公 司 及 其 附 屬 公 司（「本集團」）截 至 二 零 二 五 年 六 月 三 十 日 止 六 個 月 （「報告期」）的 未 經 審 核 中 期 業 績。 財務摘要 | | 截至六月三十日止六個月 | | | | | --- | --- | --- | --- | --- | | | 二零二五年 | 二零二四年 | | | | | 人民 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任 何 損 失 承 擔 任 何 責 任。 馬鞍山鋼鐵股份有限公司 Maanshan Iron & Steel Company Limited （在中華人民共和國註冊成立之股份有限公司） （股票代號：00323） 2025年半年度業績公告 一. 重要提示 – 1 – 1 本 半 年 度 業 績 公 告 來 自 半 年 度 報 告 全 文，為 全 面 了 解 本 公 司 的 經 營 成 果、財 務 狀 況 及 未 來 發 展 規 劃，投 資 者 應 當 仔 細 閱 讀 同 時刊載 於香港 聯合交易所有限公司網站及上海證券交易所網 站 等 中 國 證 監 會 指 定 網 站 上 的 半 年 度 報 告 全 文。 2 本 公 司 董 事 會、監 事 會 及 董 事、監 事、高 級 管 理 人 員 保 證 半 年 度 報 告 內 容 的 真 實、準 確、完 整，不 存 在 虛 假 記 載 ...

瑞 浦 蘭 鈞能源 股 份 有 限 公 司 REP T B ATTE RO Energy Co., L t d . （ 於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ） 股 份 代 號 ： 066 6 2 0 2 5 中 期 報 告 瑞 浦 限 公 司 REP T B ATTE 蘭 鈞能源 股 份 有 RO Energy Co., L t d . (A j o i nt s t o c k c o mpa ny in c o r p o rat e d in t h e P e opl e ' s R e p u b l i c of C hin a w i th limi t ed l i abi l i t y ) S t o c k C o d e: 066 6 2 0 2 5 Interim R e p o r t 瑞浦蘭鈞能源股份有限公司 REPT BATTERO Energy Co., Ltd. 2025 中期報告 Interim Report 目錄 | 公司資料 | 2 | | --- | --- | | 財務概要 | 4 | | 管理層討論及分析 | 5 | | ...